Walleye Capital’s Clover Health Investments CLOV Stock Holding History

Walleye Capital’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.1K	Sell	24,512 -82,689	-77%	-$179K	﹤0.01%	3937
2025 Q4	$252K	Buy	107,201 +28,409	+36%	+$77.7K	﹤0.01%	3419
2025 Q3	$241K	Sell	78,792 -210,404	-73%	-$601K	﹤0.01%	3187
2025 Q2	$807K	Buy	289,196 +286,280	+9,818%	+$941K	﹤0.01%	2224
2025 Q1	$10.5K	Sell	2,916 -38,014	-93%	-$153K	﹤0.01%	4060
2024 Q4	$129K	Buy	+40,930	New	+$146K	﹤0.01%	4009
2022 Q2	–	Sell	-59,002	Closed	-$209K	–	2404
2022 Q1	$209K	Buy	59,002 +2,602	+5%	+$7.54K	0.01%	1500
2021 Q4	$210K	Buy	+56,400	New	+$346K	0.01%	1444
2020 Q4	–	Sell	-101,030	Closed	-$1.26M	–	958
2020 Q3	$1.26M	Sell	101,030 -100,809	-50%	-$1.12M	0.14%	200
2020 Q2	$2.26M	Buy	+201,839	New	+$2.17M	0.5%	48

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Capital's CLOV Position: Q1 2026 in Review

Walleye Capital reduced its Clover Health Investments (CLOV) stake by 77% in Q1 2026, selling an estimated $179K and leaving 24,512 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3937.

Walleye Capital first reported a position in CLOV in Q2 2020 and has held it in 10 quarters since. The position peaked at $2.26M in Q2 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Walleye Capital held 24,512 shares of Clover Health Investments worth $43.1K as of Q1 2026.
Walleye Capital sold 82,689 Clover Health Investments shares in Q1 2026, an estimated $179K.
Clover Health Investments made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3937 holding.
Walleye Capital first reported a position in Clover Health Investments in Q2 2020 and has held it in 10 quarters since.
Walleye Capital's Clover Health Investments position peaked at $2.26M in Q2 2020.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.